State Street Corp Adaptive Biotechnologies Corp Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, State Street Corp holds 2,502,900 shares of ADPT stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,502,900

Previous 2,680,546 6.63%

Holding current value

$12.3 Million

Previous $8.6 Million 5.3%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.34 - $3.96 $415,691 - $703,478	-177,646 Reduced 6.63%	2,502,900 $9.06 Million
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $256,011 - $426,686	88,893 Added 3.43%	2,680,546 $8.6 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $195,877 - $301,741	56,612 Added 2.23%	2,591,653 $12.7 Million
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $48,606 - $80,914	-9,587 Reduced 0.38%	2,535,041 $13.8 Million
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $144,932 - $205,574	-23,414 Reduced 0.91%	2,544,628 $17.1 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $519,394 - $673,214	66,589 Added 2.66%	2,568,042 $22.7 Million
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $156,612 - $233,668	25,018 Added 1.01%	2,501,453 $19.1 Million
Q3 2022 Nov 15, 2022	BUY	$6.5 - $12.67 $890,831 - $1.74 Million	137,051 Added 5.86%	2,476,435 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $2.98 Million - $6.85 Million	464,913 Added 24.8%	2,339,384 $18.9 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $2.47 Million - $7.04 Million	243,581 Added 14.94%	1,874,471 $26 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $2.65 Million - $3.87 Million	105,132 Added 6.89%	1,630,890 $45.8 Million
Q3 2021 Nov 15, 2021	BUY	$30.02 - $39.87 $2.97 Million - $3.94 Million	98,837 Added 6.93%	1,525,758 $51.9 Million
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $15.3 Million - $21.1 Million	473,378 Added 49.64%	1,426,921 $58.3 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $66,732 - $121,322	-1,791 Reduced 0.19%	953,543 $38.4 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $1.56 Million - $2.28 Million	34,767 Added 3.78%	955,334 $56.5 Million
Q3 2020 Nov 10, 2020	BUY	$35.79 - $48.81 $3.84 Million - $5.23 Million	107,210 Added 13.18%	920,567 $44.8 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $2.48 Million - $4.81 Million	99,461 Added 13.93%	813,357 $39.4 Million
Q1 2020 May 11, 2020	BUY	$16.96 - $34.16 $12.1 Million - $24.4 Million	713,896 New	713,896 $19.8 Million

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $700M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Adaptive Biotechnologies Corp Transaction History